Alain B. Schreiber
6Patents
3h-index
11Co-inventors
46Inventor score
Filing activity: Mar 30, 1984 → Mar 5, 1990
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4686283A | Analogs of transforming and epidermal growth factor fragments for therapy and diagnosis | Emerging Cross-Sectional Technologies | 30 | Expired |
| US4599331A | Etianic acids as antiangiogenics | Human Necessities | 15 | Expired |
| US4782015A | Method for determining the presence of malignant cells | Emerging Cross-Sectional Technologies | 9 | Expired |
| US4861795A | Treatment of conditions requiring enhanced oxygen availability to mammalian tissues | Human Necessities | 3 | Expired |
| US4948582A | Treatment of conditions requiring enhanced oxygen availability to mammalian tissues | Human Necessities | 2 | Expired |
| US5015663A | Treatment of conditions requiring enhanced oxygen availability of mammalian tissues | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.